Antimicrobial Agents and Chemotherapy · 2020 · 16 citations · 27 references
PharmacyPharmacokineticsPharmacologyClinical PharmacologyPharmacokinetic ModelingPopulation PharmacokineticsDose OptimizationNeonatal Drug TherapyNeonatal PharmacologyPediatric Drug DosingPediatric PharmacokineticsPediatric PharmacologyDose Adjustment In NeonatesDosing In Premature InfantsDrug Dosing In PrematurityNeonatal DosingNeonate DosingOptimal DesignPediatric Population PharmacokineticsPharmacokinetics In Neonates
Our objective was to develop a population pharmacokinetic (PK) model in order to evaluate the currently recommended dosing regimen in term and preterm neonates. By using an optimal design approach, a prospective PK study was designed and implemented in 60 neonates with postmenstrual ages (PMA) of 26 to 43 weeks. A loading dose of 16 mg/kg was administered at day 1, followed by a maintenance dose of 8 mg/kg daily. Plasma concentrations were quantified by high-pressure liquid chromatography–mass spectrometry.
27
Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
Michael Neely, Gilmer Youn, Brenda Jones et al. · Antimicrobial Agents and Chemotherapy · 2013 · 390 citations · Full text
Ann Versporten, Julia Bielicki, Nico Drapier et al. · Journal of Antimicrobial Chemotherapy · 2016 · 318 citations · Full text
Pharmacy, Child Health, Pediatrics +17
Clinical Pharmacokinetics of Teicoplanin
Alison Wilson · Clinical Pharmacokinetics · 2000 · 247 citations